Re: GAM analysis and further action

From: Marc Gastonguay Date: March 29, 2006 technical Source: cognigencorp.com
From: "Gastonguay, Marc" marcg@metrumrg.com Subject: Re: [NMusers] GAM analysis and further action Date: Wed, 29 Mar 2006 16:01:36 -0500 Dennis - We'd probably all agree that modeling results are not effective unless presented in a useful clinical perspective. This doesn't mean that we have to use a less than adequate model, though. In fact, it has been shown that this can lead to biased interpretation of other model components (Wade et al J Pharmacokinet Biopharm 1994; 22(2):165-77). As Manish suggested, this is definitely a concern in pediatrics when body-size and age-dependent changes in physiology are correlated. We can actually meet both goals; build models that are structurally consistent with known physiology and observed data and then use these models as simulation tools to explore the impact of simpler clinical guidance. Best regards, Marc Marc R. Gastonguay, Ph.D. www.metrumrg.com
Mar 29, 2006 Toufigh Gordi GAM analysis and further action
Mar 29, 2006 Mats Karlsson RE: GAM analysis and further action
Mar 29, 2006 Paul Hutson Re: GAM analysis and further action
Mar 29, 2006 Jakob Ribbing RE: GAM analysis and further action
Mar 29, 2006 Manish Gupta Re: GAM analysis and further action
Mar 29, 2006 Mark Sale RE: GAM analysis and further action
Mar 29, 2006 Dennis Fisher GAM analysis and further action
Mar 29, 2006 Steven B Charnick RE: GAM analysis and further action
Mar 29, 2006 Marc Gastonguay Re: GAM analysis and further action
Mar 29, 2006 Nick Holford Re: GAM analysis and further action
Mar 30, 2006 Jakob Ribbing RE: GAM analysis and further action